ティーセルヌーヴォー株式会社
ActiveT Cell Nouveau is a clinical-stage biopharmaceutical company that focuses on curing solid tumors with hybrid CAR-T cell therapy.
What it does
"T Cell Nouveau is a pioneering medtech company dedicated to revolutionizing cancer treatment. Leveraging cutting-edge technology and precise cellular power, we are developing a novel CAR-T cell therapy targeting the cancer antigen GD2. Our research enables specific attacks on intracellular cancer, enhancing the efficiency and safety of cancer treatment. Committed to organizational growth and evolution, we continuously strive for innovation through initiatives such as website renewal and executive appointments. Headquartered in Tokyo, we can be reached at +81-3-6555-3304. Join us in our mission to provide innovative solutions for curing solid tumors with hybrid CAR-T cell therapy."
Next to it in Healthcare and bio · CAR-T cell therapy for solid tumors
- Convalesce IncSOSV SOSV IndieBio 07
Stem cell therapy for neurodegenerative diseases
- セレイドセラピューティクス株式会社Plug and Play
Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
- クオリプス株式会社Plug and Play
CUORiPS is a company developing new medical care based on world's cutting-edge technology originated in Japan.
- マイキャン・テクノロジーズ株式会社Plug and Play
MiCAN Technologies medical and nursing Care company.
- 株式会社セルファイバPlug and Play
Cell fiber technology was developed as a basic technology for handling cells in the engineering field.
- CytoronixPlug and Play
Accelerating Next Generation Cell Medicine
- Regcell Co., Ltd.Plug and Play
Regcell is a university-originated venture company and aims to develop novel immunotherapies for immunological diseases and cancer by targeting regulatory T cells, which are specialized for immune suppression.
- AikomiPlug and Play
Aikomi is a Japanese company developing digital therapy for dementia